The Business Research Company’s report on the D Dimer Testing Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the d dimer testing market further?
The increasing prevalence of cancer is expected to propel the growth of the d-dimer testing market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. D-dimer testing is primarily used to help diagnose, monitor, and treat cancer patients and assess the risk of blood clot formation. It monitors thrombotic events in various clinical settings. For instance, in January 2022, according to research published by the American Cancer Society, a US-based health organization, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in the US in 2022. It is about 1,670 fatalities each day. Therefore, the increasing prevalence of cancer is driving the growth of the d-dimer testing market.
Access Your Free Sample of the Global D Dimer Testing Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12341&type=smp
What are the key factors influencing the forecasted market size of the d dimer testing industry?
The D dimer testing market size has grown steadily in recent years. It will grow from $1.47 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to the emergence of thrombosis research, improvements in laboratory techniques, clinical validation of d-dimer as a marker, and a shift in diagnostic protocols
The D dimer testing market size is expected to see strong growth in the next few years. It will grow to $1.9 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the increasing geriatric population, growth in point-of-care testing (POCT), integration with risk assessment algorithms, increased awareness and education campaigns, regulatory guidance and standardization. Major trends in the forecast period include biomarker combinations for enhanced diagnosis, focus on rapid and accurate results, d-dimer testing in COVID-19 management, remote monitoring and home-based testing kits, continuous monitoring, and serial testing.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12341&type=smp
Who are the leading competitors in the d dimer testing market?
Major companies operating in the D dimer testing market include Kaiser Foundation Health Plan Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson And Company (BD), Laboratory Corporation, Quest Diagnostics Inc., bioMérieux SA, Beckman Coulter Inc., Quidel Corporation, QuidelOrtho Corporation, Sysmex Corporation, Horiba Ltd., Werfen SA, Helena Laboratories Corporation, Abcam plc, LumiraDx Limited, Personalabs, Sekisui Diagnostics LLC, Diagnostica Stago S.A.S., RayBiotech Inc., CTK Biotech Inc., Diazyme Laboratories Inc., AdvaCare Pharma USA, UCP Biosciences Inc., AccuBioTech Co Ltd., Response Biomedical Corporation
Which emerging trends are set to transform the d dimer testing market landscape?
Major companies operating in the D-dimer testing market are adopting a strategic partnership approach to gain exclusive rights to D-dimer testing solutions and gain a competitive edge in the market. Strategic partnerships refer to a process in which companies leverage each other’s strengths and resources to achieve mutual benefits and success. For instance, in March 2022, SphingoTec GmbH, a Germany-based biotechnology company, partnered with Rivaara Labs Pvt Ltd., an India-based medical laboratory and healthcare company. Under this partnership, Rivaara gains exclusive rights to market and distribute SphingoTec’s point-of-care tests featuring innovative biomarkers in the Indian subcontinent. These biomarkers encompass proenkephalin (penKid) for kidney function assessment, bioactive adrenomedullin (bio-ADM) for endothelial function evaluation, and dipeptidyl peptidase 3 (DPP3) as a biomarker for cardiac depression. These pioneering markers are supplemented by commonly utilized parameters such as procalcitonin, troponin, D-dimer, NT-proBNP, and TSH.
How do different geographies compare in terms of market share and growth potential in the d dimer testing market?
North America was the largest region in the D dimer testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the D dimer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/d-dimer-testing-global-market-report
Which major segments of the d dimer testing market are experiencing the fastest growth?
The D dimer testing market covered in this report is segmented –
1) By Test: Clinical Laboratory Tests, Point-Of-Care Tests
2) By Product: Analyzers, Reagents And Consumables
3) By Method: Enzyme-linked Immunosorbent Assay (ELISA), Latex-enhanced Immuno-turbidimetric Assays, Fluorescence Immunoassays, Other Testing Method
4) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Application
5) By End-User: Hospitals, Academic And Research Institutes, Diagnostic Centers, Other End-User
Subsegments:
1) By Clinical Laboratory Tests: Enzyme-Linked Immunosorbent Assay (Elisa), Chemiluminescent Immunoassay (CLIA), Latex Agglutination Assays, Other Laboratory Testing Methods
2) By Point-Of-Care Tests: Rapid Test Kits, Portable Testing Devices, Lateral Flow Assays, Other Point-Of-Care Testing Methods
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12341
How is the d dimer testing market defined, and what are its core characteristics?
D-dimer testing refers to laboratory blood testing that measures the d-dimer level in the bloodstream. D-dimer is a protein fragment produced when a blood clot breaks down in the body. The test is primarily used to help diagnose or rule out the presence of blood clots, particularly in conditions such as deep vein thrombosis (DVT) or pulmonary embolism (PE).
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
